Tert-butyl 4-(4-bromo-3-chlorobenzoyl)piperazine-1-carboxylate;tert-butyl 4-[3-chloro-4-(1H-indol-5-yl)benzoyl]piperazine-1-carboxylate;[3-chloro-4-(1-propan-2-ylindol-5-yl)phenyl]-[4-(1-hydroxycyclopropanecarbonyl)piperazin-1-yl]methanone;1-hydroxycyclopropane-1-carboxylic acid;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
C85H102BBrCl3N9O14 — CID 158552219
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-(4-bromo-3-chlorobenzoyl)piperazine-1-carboxylate;tert-butyl 4-[3-chloro-4-(1H-indol-5-yl)benzoyl]piperazine-1-carboxylate;[3-chloro-4-(1-propan-2-ylindol-5-yl)phenyl]-[4-(1-hydroxycyclopropanecarbonyl)piperazin-1-yl]methanone;1-hydroxycyclopropane-1-carboxylic acid;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Tert-butyl 4-(4-bromo-3-chlorobenzoyl)piperazine-1-carboxylate;tert-butyl 4-[3-chloro-4-(1H-indol-5-yl)benzoyl]piperazine-1-carboxylate;[3-chloro-4-(1-propan-2-ylindol-5-yl)phenyl]-[4-(1-hydroxycyclopropanecarbonyl)piperazin-1-yl]methanone;1-hydroxycyclopropane-1-carboxylic acid;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (PubChem CID 158552219) has the molecular formula C85H102BBrCl3N9O14 and a molecular weight of 1670.87 g/mol. Its IUPAC name is tert-butyl 4-(4-bromo-3-chlorobenzoyl)piperazine-1-carboxylate;tert-butyl 4-[3-chloro-4-(1H-indol-5-yl)benzoyl]piperazine-1-carboxylate;[3-chloro-4-(1-propan-2-ylindol-5-yl)phenyl]-[4-(1-hydroxycyclopropanecarbonyl)piperazin-1-yl]methanone;1-hydroxycyclopropane-1-carboxylic acid;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole.
Molecular Properties
| Compound Name | Tert-butyl 4-(4-bromo-3-chlorobenzoyl)piperazine-1-carboxylate;tert-butyl 4-[3-chloro-4-(1H-indol-5-yl)benzoyl]piperazine-1-carboxylate;[3-chloro-4-(1-propan-2-ylindol-5-yl)phenyl]-[4-(1-hydroxycyclopropanecarbonyl)piperazin-1-yl]methanone;1-hydroxycyclopropane-1-carboxylic acid;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole |
|---|---|
| PubChem CID | 158552219 |
| Molecular Formula | C85H102BBrCl3N9O14 |
| Molecular Weight | 1670.87 g/mol |
| Exact Mass | 1667.59 |
| IUPAC Name | tert-butyl 4-(4-bromo-3-chlorobenzoyl)piperazine-1-carboxylate;tert-butyl 4-[3-chloro-4-(1H-indol-5-yl)benzoyl]piperazine-1-carboxylate;[3-chloro-4-(1-propan-2-ylindol-5-yl)phenyl]-[4-(1-hydroxycyclopropanecarbonyl)piperazin-1-yl]methanone;1-hydroxycyclopropane-1-carboxylic acid;methane;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole |
| SMILES | C.CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(-c3ccc4[nH]ccc4c3)c(Cl)c2)CC1.CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(Br)c(Cl)c2)CC1.CC(C)n1ccc2cc(-c3ccc(C(=O)N4CCN(C(=O)C5(O)CC5)CC4)cc3Cl)ccc21.CC1(C)OB(c2ccc3[nH]ccc3c2)OC1(C)C.O=C(O)C1(O)CC1 |
| InChI | InChI=1S/C26H28ClN3O3.C24H26ClN3O3.C16H20BrClN2O3.C14H18BNO2.C4H6O3.CH4/c1-17(2)30-10-7-19-15-18(4-6-23(19)30)21-5-3-20(16-22(21)27)24(31)28-11-13-29(14-12-28)25(32)26(33)8-9-26;1-24(2,3)31-23(30)28-12-10-27(11-13-28)22(29)18-4-6-19(20(25)15-18)16-5-7-21-17(14-16)8-9-26-21;1-16(2,3)23-15(22)20-8-6-19(7-9-20)14(21)11-4-5-12(17)13(18)10-11;1-13(2)14(3,4)18-15(17-13)11-5-6-12-10(9-11)7-8-16-12;5-3(6)4(7)1-2-4;/h3-7,10,15-17,33H,8-9,11-14H2,1-2H3;4-9,14-15,26H,10-13H2,1-3H3;4-5,10H,6-9H2,1-3H3;5-9,16H,1-4H3;7H,1-2H2,(H,5,6);1H4 |
| InChIKey | HPVZWDGZSCQRQH-UHFFFAOYSA-N |
| XLogP | 16.03 |
| TPSA | 273.05 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 113 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1670.87 |
| LogP ≤ 5 | 16.03 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158552219 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.